TBX3 and SNAI2 mRNA levels were significantly lower in high‐grade breast cancers than in low‐ and intermediate‐grade breast cancers (Figure 5D) (p < 0.001), consistent with our immunohistochemical data. The gene discussed is SNAI2; the disease is breast cancer.